Aytu BioPharma (AYTU) Short Interest Ratio & Short Volume $2.40 -0.04 (-1.64%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.40 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Aytu BioPharma Short Interest DataAytu BioPharma (AYTU) has a short interest of 527,100 shares, representing 9.76% of the float (the number of shares available for trading by the public). This marks a 7.05% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 151,752 shares to cover all short positions.Current Short Interest527,100 sharesPrevious Short Interest492,400 sharesChange Vs. Previous Month+7.05%Dollar Volume Sold Short$1.14 millionShort Interest Ratio0.4 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares8,980,000 sharesFloat Size5,400,000 sharesShort Percent of Float9.76%Today's Trading Volume86,793 sharesAverage Trading Volume151,752 sharesToday's Volume Vs. Average57% Short Selling Aytu BioPharma? Sign up to receive the latest short interest report for Aytu BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAYTU Short Interest Over TimeAYTU Days to Cover Over TimeAYTU Percentage of Float Shorted Over Time Aytu BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025527,100 shares $1.14 million +7.1%9.8%0.4 $2.17 6/30/2025492,400 shares $1.07 million -21.2%9.1%0.4 $2.18 6/15/2025624,600 shares $1.22 million +49.9%11.6%0.5 $1.95 5/31/2025416,700 shares $741.73 thousand -43.7%7.0%0.3 $1.78 5/15/2025740,400 shares $1.92 million +445.2%12.4%0.6 $2.59 4/30/2025135,800 shares $183.33 thousand +14.4%2.3%3.7 $1.35 4/15/2025118,700 shares $123.45 thousand +1.2%2.0%3.5 $1.04 3/31/2025117,300 shares $140.76 thousand +2.3%2.0%3.4 $1.20 3/15/2025114,700 shares $138.20 thousand -4.7%1.9%3.5 $1.20 2/28/2025120,400 shares $155.32 thousand -2.8%2.0%3.5 $1.29 Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025123,900 shares $171.60 thousand -3.0%2.1%3.8 $1.39 1/31/2025127,700 shares $218.37 thousand -3.0%2.2%3.7 $1.71 1/15/2025131,600 shares $215.17 thousand -4.2%2.2%3.7 $1.64 12/31/2024137,300 shares $233.41 thousand +8.3%2.3%4.1 $1.70 12/15/2024126,800 shares $182.59 thousand +7.1%2.1%3.4 $1.44 11/30/2024118,400 shares $190.62 thousand -2.0%2.0%3.4 $1.61 11/15/2024120,800 shares $190.86 thousand -37.3%2.0%4.1 $1.58 10/31/2024192,800 shares $370.18 thousand -14.4%3.2%7.8 $1.92 10/15/2024225,200 shares $515.71 thousand -14.1%3.8%10.5 $2.29 9/30/2024262,300 shares $616.41 thousand -17.0%4.4%11.9 $2.35 9/15/2024315,900 shares $815.02 thousand -2.5%5.5%18.3 $2.58 8/31/2024324,000 shares $810 thousand -0.3%5.6%16.4 $2.50 8/15/2024324,800 shares $843.18 thousand -12.8%5.6%14.6 $2.60 7/31/2024372,500 shares $987.13 thousand -6.0%6.5%16.8 $2.65 7/15/2024396,200 shares $1.12 million -3.8%6.9%19.3 $2.82 6/30/2024411,700 shares $1.20 million -9.7%7.2%19.6 $2.92 6/15/2024455,900 shares $1.30 million -1.6%7.9%21.7 $2.85 5/31/2024463,400 shares $1.46 million +10.5%8.7%24 $3.15 5/15/2024419,400 shares $1.28 million +9.5%7.8%21.7 $3.06 4/30/2024383,000 shares $1.08 million -4.8%7.2%18.5 $2.81 4/15/2024402,500 shares $1.07 million +11.5%7.5%19.8 $2.67 3/31/2024360,900 shares $1.10 million -0.2%6.7%18 $3.04 3/15/2024361,600 shares $1.04 million +3.5%6.8%16.9 $2.87 2/29/2024349,500 shares $1.01 million +4.4%6.5%14.8 $2.89 2/15/2024334,900 shares $1.04 million +6.3%6.3%14.6 $3.12 1/31/2024315,100 shares $860.22 thousand -9.6%5.9%11 $2.73 1/15/2024348,500 shares $892.16 thousand -7.4%6.5%9.1 $2.56 12/31/2023376,300 shares $1.07 million -8.2%7.0%7.9 $2.84 12/15/2023409,800 shares $1.20 million -11.7%7.7%2.5 $2.93 11/30/2023464,000 shares $1.06 million -23.1%8.7%2.8 $2.29Trump Did What!? (Ad)Last May, President Trump signed four executive orders that could spark the biggest energy disruption in decades. This move opens the door for a next-gen power source with the potential to upend oil and gas, slash emissions, and accelerate artificial intelligence breakthroughs. While stocks tied to this trend have already soared, one overlooked corner of the industry could deliver even bigger gains—and it’s still flying under the radar.Get the name and ticker of the breakout stock positioned for this energy revolution. 11/15/2023603,000 shares $1.38 million -4.7%11.3%3.7 $2.29 10/31/2023632,800 shares $1.73 million -14.9%12.1%4 $2.73 10/15/2023743,200 shares $2.22 million +112.6%14.2%4.8 $2.99 9/30/2023349,600 shares $943.92 thousand +5.8%9.8%2.4 $2.70 9/15/2023330,300 shares $535.09 thousand -6.4%9.3%11.2 $1.62 8/31/2023352,800 shares $599.76 thousand +12.0%9.9%8.9 $1.70 8/15/2023314,900 shares $588.86 thousand -1.7%8.8%6.8 $1.87 7/31/2023320,200 shares $579.56 thousand -6.2%8.9%5.6 $1.81 7/15/2023341,500 shares $638.61 thousand -8.8%9.5%4.1 $1.87 6/30/2023374,600 shares $599.36 thousand -39.3%10.5%4.4 $1.60 6/15/2023616,700 shares $1.14 million +3.3%17.2%7.4 $1.85 5/31/2023596,800 shares $996.66 thousand -0.1%16.6%7.4 $1.67 5/15/2023597,300 shares $1.07 million +23.6%16.6%7.2 $1.79 4/30/2023483,200 shares $1.14 million -9.6%14.3%6.2 $2.35 4/15/2023534,300 shares $1.36 million +4.1%15.8%9.8 $2.55 3/31/2023513,200 shares $1.15 million +3.1%15.2%7.9 $2.24 3/15/2023497,600 shares $1.17 million +0.8%14.7%6.2 $2.35 2/28/2023493,900 shares $1.31 million +12.3%15.3%6.4 $2.66 2/15/2023440,000 shares $1.31 million +8.7%13.7%5.7 $2.98 1/31/2023404,700 shares $1.34 million +16.9%12.5%5.3 $3.30 1/15/2023346,300 shares $1.20 million +99.3%10.8%4.8 $3.47 12/30/2022173,800 shares $32.85 thousand -93.9%N/A2.8 $0.19 12/15/20222,830,000 shares $602.51 thousand -6.3%N/A2.6 $0.21 11/30/20223,020,000 shares $619.40 thousand +24.8%N/A3 $0.21 11/15/20222,420,000 shares $473.11 thousand +36.0%N/A2.3 $0.20 10/31/20221,780,000 shares $291.92 thousand No ChangeN/A1.3 $0.16 10/15/20221,780,000 shares $295.66 thousand +17.9%N/A1.3 $0.17 9/30/20221,510,000 shares $279.35 thousand +42.5%N/A1.1 $0.19 9/15/20221,060,000 shares $231.08 thousand -8.6%N/A0.8 $0.22 8/31/20221,160,000 shares $258.10 thousand -22.2%N/A1 $0.22 8/15/20221,490,000 shares $427.63 thousand +29.6%N/A1.5 $0.29 7/31/20221,150,000 shares $598 thousand -0.9%N/A1.5 $0.52 7/15/20221,160,000 shares $694.84 thousand -12.1%N/A2 $0.60 6/30/20221,320,000 shares $910.80 thousand No ChangeN/A1.1 $0.69 6/15/20221,320,000 shares $646.80 thousand +11.9%N/A1.3 $0.49 5/31/20221,180,000 shares $644.28 thousand -15.1%N/A1.2 $0.55 5/15/20221,390,000 shares $717.52 thousand -17.3%N/A1.4 $0.52 4/30/20221,680,000 shares $1.08 million +7.7%N/A1.7 $0.65 4/15/20221,560,000 shares $1.46 million -6.0%N/A1.7 $0.93 3/31/20221,660,000 shares $1.79 million -11.7%N/A8.7 $1.08 3/15/20221,880,000 shares $2.05 million +2.2%N/A7.6 $1.09 2/28/20221,840,000 shares $2.32 million +0.6%N/A4.7 $1.26 2/15/20221,830,000 shares $2.43 million +15.8%N/A4.2 $1.33 1/31/20221,580,000 shares $2.07 million -8.7%N/A3.3 $1.31 1/15/20221,730,000 shares $2.34 million +13.8%N/A3.5 $1.35 12/31/20211,520,000 shares $2.05 million -15.1%N/A3.1 $1.35 12/15/20211,790,000 shares $2.83 million +1.7%N/A3.7 $1.58 11/30/20211,760,000 shares $3.45 million +8.6%N/A3.9 $1.96 11/15/20211,620,000 shares $3.97 million -16.1%N/A4.3 $2.45 10/29/20211,930,000 shares $4.81 million +31.3%7.8%5.6 $2.49Trump Did What!? (Ad)Last May, President Trump signed four executive orders that could spark the biggest energy disruption in decades. This move opens the door for a next-gen power source with the potential to upend oil and gas, slash emissions, and accelerate artificial intelligence breakthroughs. While stocks tied to this trend have already soared, one overlooked corner of the industry could deliver even bigger gains—and it’s still flying under the radar.Get the name and ticker of the breakout stock positioned for this energy revolution. 10/15/20211,470,000 shares $3.90 million -31.0%5.9%4.2 $2.65 9/30/20212,130,000 shares $6.13 million -4.9%8.7%5.5 $2.88 9/15/20212,240,000 shares $6.81 million +18.5%10.2%4.4 $3.04 8/31/20211,890,000 shares $7.18 million -6.0%8.6%2.4 $3.80 8/13/20212,010,000 shares $6.95 million -8.6%9.1%2.2 $3.46 7/30/20212,200,000 shares $8.73 million +12.8%10.0%2.3 $3.97 7/15/20211,950,000 shares $8.39 million +21.9%8.9%2.1 $4.30 6/30/20211,600,000 shares $8.02 million -37.5%7.3%1.7 $5.01 6/15/20212,560,000 shares $13.21 million +2.8%11.7%3 $5.16 5/28/20212,490,000 shares $12.65 million +7.3%11.5%3.4 $5.08 5/14/20212,320,000 shares $12.11 million +11.5%N/A3.6 $5.22 4/30/20212,080,000 shares $13.96 million +12.4%N/A3 $6.71 4/15/20211,850,000 shares $12.62 million +25.0%N/A2.7 $6.82 3/31/20211,480,000 shares $10.98 million +148.2%N/A2 $7.42 3/15/2021596,400 shares $5.12 million +60.1%3.7%0.8 $8.59 2/26/2021372,600 shares $2.94 million +9.4%2.3%0.4 $7.90 2/12/2021340,700 shares $2.98 million +1.8%2.1%0.4 $8.74 1/29/2021334,800 shares $2.44 million -26.6%2.1%0.4 $7.29 1/15/2021456,000 shares $3.37 million -37.9%2.9%0.6 $7.39 12/31/2020734,600 shares $4.44 million -8.4%4.9%1 $6.04 12/15/2020801,800 shares $4.80 million -91.7%5.3%1.2 $5.99 11/30/20209,710,000 shares $8.93 million +7.3%86.3%29.2 $0.92 11/15/20209,050,000 shares $8.77 million -10.1%N/A2.8 $0.97 10/30/202010,070,000 shares $9.87 million -9.9%N/A3.1 $0.98 10/15/202011,180,000 shares $11.85 million -2.4%N/A3.1 $1.06 9/30/202011,450,000 shares $13.63 million +129.0%N/A2.6 $1.19 9/15/20205,000,000 shares $5.90 million -6.2%N/A0.9 $1.18 8/31/20205,330,000 shares $5.65 million -12.1%N/A0.9 $1.06 8/14/20206,060,000 shares $7.82 million -19.6%N/A0.9 $1.29 AYTU Short Interest - Frequently Asked Questions What is Aytu BioPharma's current short interest? Short interest is the volume of Aytu BioPharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 527,100 shares of AYTU short. 9.76% of Aytu BioPharma's shares are currently sold short. Learn More on Aytu BioPharma's current short interest. What is a good short interest percentage for Aytu BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.76% of Aytu BioPharma's floating shares are currently sold short. Is Aytu BioPharma's short interest increasing or decreasing? Aytu BioPharma saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 527,100 shares, an increase of 7.0% from the previous total of 492,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aytu BioPharma's float size? Aytu BioPharma currently has issued a total of 8,980,000 shares. Some of Aytu BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aytu BioPharma currently has a public float of 5,400,000 shares. How does Aytu BioPharma's short interest compare to its competitors? 9.76% of Aytu BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aytu BioPharma: Invivyd, Inc. (5.87%), Adagene Inc. Sponsored ADR (0.17%), Adaptimmune Therapeutics PLC (1.46%), Vaxart, Inc. (3.83%), Metagenomi, Inc. (6.10%), VistaGen Therapeutics, Inc. (1.91%), Oramed Pharmaceuticals Inc. (0.99%), XBiotech Inc. (2.65%), Entera Bio Ltd. (0.08%), Milestone Pharmaceuticals Inc. (9.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Aytu BioPharma stock? Short selling AYTU is an investing strategy that aims to generate trading profit from Aytu BioPharma as its price is falling. AYTU shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aytu BioPharma? A short squeeze for Aytu BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AYTU, which in turn drives the price of the stock up even further. How often is Aytu BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AYTU, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies IVVD Short Interest Data ADAG Short Interest Data ADAP Short Interest Data VXRT Short Interest Data MGX Short Interest Data VTGN Short Interest Data ORMP Short Interest Data XBIT Short Interest Data ENTX Short Interest Data MIST Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AYTU) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.